F.A.Q.

Send your suggestions, comments and questions to our doctors and pharmacists.

GD-100 capsules are safe to use for a long period of time without any side effects. In case of allergic reactions, such as rash, red skin, nausea, vomiting, and diarrhea, please consult with to your physician.

GD-100 capsules should be taken half an hour after breakfast, with a glass of warm water, and in the evening, after supper, with a glass of warm water.

The GD-100 capsules are not recommended during pregnancy and breastfeeding.

The GD-100 capsules are not recommended for children less than 12 years of age.

Yes, these patients may use GD-100 capsules. However, the GD-100 is not a therapy for these conditions.

Yes, GD-100 may be used in these patients. However, there are no data about treating ulcerative colitis with the GD-100 preparation.

GD-100 capsules are safe to combine with other medications. There are no reported drug interactions. A caution is required when anticoagulant therapy is administered in combination with the GD-100. In these instances physician monitoring is recommended.

For now, there are no reported negative side effects.

GD-100 is an efficient immunomodulator, a dietary supplement and not a cure for malignant diseases. But it could be a great help if used in combination with standard, conventional cancer therapy.

GD-100 is a natural immunomodulator. That means that it instigates the growth of the healthy cells while at the same time "killing" the tumor cells using various mechanisms (please see the list of references), thus achieving the aforementioned selective effect.

The capsule may not be opened. The patients that have difficulties with swallowing may take the GD-100 with the liquid meal.

The length of the therapy and the effects greatly depend on the nature and the degree of illness, as well as the individual patient response to the therapy.

Studies about bioactive Genoderma Lucidum substances have been published in various countries and medical journals. For more detailed list please visit: Studies